RemedyRepack Inc. recalls Ranitidine 150 mg tablet Original Supplier's NDC 65162-0253-10 Remedy Repackaged NDC 70518-1714-00
RemedyRePack recalls Ranitidine 150mg tablets with potential NDMA levels above safety limits. Consumers should check lot numbers and contact the company for details.
Stop using this now
CGMP Deviation; Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.
Contact the company & request your remedy
What happened, in plain English
RemedyRePack is recalling certain Ranitidine 150mg tablets due to possible unsafe levels of NDMA. This chemical has been linked to health risks, so affected consumers should stop using the product. Read more at govinfonow.com/recall/37657-ranitidine-150mg-tablets-recall-nitrosodimethylamine-ndma-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37657-ranitidine-150mg-tablets-recall-nitrosodimethylamine-ndma-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0798-2020
Cite this page
“Ranitidine 150mg Tablets Recall: Nitrosodimethylamine (NDMA) Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37657-ranitidine-150mg-tablets-recall-nitrosodimethylamine-ndma-risk. Based on FDA recall #D-0798-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0798-2020%22&limit=1).
Why it’s dangerous
The tablets may contain higher levels of NDMA than allowed by safety standards. NDMA is a potential carcinogen that could increase cancer risk with long-term use.
Who’s affected
People who own or use the recalled Ranitidine 150mg tablets with specific lot numbers listed in the recall. Those with the tablets from the original supplier (NDC 65162-0253-10) repackaged by RemedyRePack are most at risk.
How to tell if you have this one
Check the lot numbers on the tablet packaging: J0376034-052319 (exp. 05/2020), J0406133-093019 (exp. 10/2020), J038005-082719 (exp. 08/2020), J0390280-072519 (exp. 07/2020), J0390277-072519 (exp. 07/2020), or J0349352-012519 (exp. 01/2020).
- Brand
RemedyRePack- Category
Drug
What to do — step by step
Stop Using Tablets Now
Immediately stop using the recalled Ranitidine 150mg tablets with the listed lot numbers.
Questions people ask
What is the risk of using these tablets?
The tablets may contain higher levels of NDMA than allowed, which is a potential carcinogen linked to increased cancer risk.
How can I check if my tablets are recalled?
Check the lot numbers on the packaging: J0376034-052319 (exp. 05/2020), J0406133-093019 (exp. 10/2020), J038005-082719 (exp. 08/2020), J0390280-072519 (exp. 07/2020), J0390277-072519 (exp. 07/2020), or J0349352-012519 (exp. 01/2020).
Do I need to return the tablets?
The recall does not specify a return process, but you should stop using the tablets immediately.
Contact RemedyRePack
We’ve drafted a message you can send RemedyRePack to request your refund or repair — edit it as you like.
Subject: Recall D-0798-2020 — RemedyRePack RemedyRePack Hello, I own a RemedyRePack that is covered by recall D-0798-2020 from RemedyRePack. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0798-2020 (December 11, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0798-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.